case_images: PMC5778721_01
case_images: 18F-fluoride positron emission tomography/computed tomography bone scan - abnormalities found in the brain parenchyma
case_images: WJNM-17-65-g001.jpg
case_images: PMC5778721_01_WJNM-17-65-g001.jpg
case_images: F1
case_images: Figure 1 shows the abnormalities found in the brain parenchyma detected by the 18F-fluoride PET/CT bone scan, which are more subtle when compared with the somatostatin receptor imaging in Figure 2, using 68Ga DOTANOC PET/CT. Figures 1 and 2 both correspond to the postgadolinium MRI findings as shown in Figure 3.
case_images: 68Ga DOTANOC positron emission tomography/computed tomography - abnormal uptake in brain parenchyma
case_images: WJNM-17-65-g002.jpg
case_images: PMC5778721_01_WJNM-17-65-g002.jpg
case_images: F2
case_images: Figure 1 shows the abnormalities found in the brain parenchyma detected by the 18F-fluoride PET/CT bone scan, which are more subtle when compared with the somatostatin receptor imaging in Figure 2, using 68Ga DOTANOC PET/CT. Figures 1 and 2 both correspond to the postgadolinium MRI findings as shown in Figure 3.
case_images: Magnetic resonance imaging confirming cerebral metastases
case_images: WJNM-17-65-g003.jpg
case_images: PMC5778721_01_WJNM-17-65-g003.jpg
case_images: F3
case_images: Figures 1 and 2 both correspond to the postgadolinium MRI findings as shown in Figure 3.